Fluidigm Corp. (NASDAQ:FLDM)’s share price was up 3.8% during mid-day trading on Tuesday . The company traded as high as $10.20 and last traded at $10.14, with a volume of 69,314 shares. The stock had previously closed at $9.77.

A number of equities analysts have recently issued reports on FLDM shares. Leerink Swann restated an “outperform” rating and set a $20.00 price objective on shares of Fluidigm Corp. in a research report on Friday, April 1st. Mizuho lowered their price objective on Fluidigm Corp. from $11.00 to $8.00 and set a “buy” rating for the company in a research report on Thursday, May 5th. Cantor Fitzgerald restated a “buy” rating and set a $13.00 price objective on shares of Fluidigm Corp. in a research report on Friday, May 6th. Zacks Investment Research downgraded Fluidigm Corp. from a “hold” rating to a “sell” rating in a research report on Wednesday, May 11th. Finally, Deutsche Bank AG started coverage on Fluidigm Corp. in a research report on Wednesday, June 1st. They set a “buy” rating for the company. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Fluidigm Corp. has an average rating of “Buy” and a consensus price target of $13.74.

The company has a 50 day moving average of $9.75 and a 200-day moving average of $8.44. The firm’s market capitalization is $295.04 million.

Fluidigm Corp. (NASDAQ:FLDM) last released its quarterly earnings results on Thursday, May 5th. The company reported ($0.40) earnings per share for the quarter, beating the consensus estimate of ($0.53) by $0.13. The firm had revenue of $29 million for the quarter, compared to the consensus estimate of $26.95 million. Fluidigm Corp.’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.25) earnings per share. Equities analysts forecast that Fluidigm Corp. will post ($2.24) EPS for the current fiscal year.

A hedge fund recently bought a new stake in Fluidigm Corp. stock. Marshall Wace LLP bought a new position in Fluidigm Corp. (NASDAQ:FLDM) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 96,680 shares of the company’s stock, valued at approximately $1,045,000. Marshall Wace LLP owned approximately 0.34% of Fluidigm Corp. as of its most recent SEC filing.

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.